POLYXEN Trademark

Trademark Overview


On Wednesday, May 16, 2001, a trademark application was filed for POLYXEN with the United States Patent and Trademark Office. The USPTO has given the POLYXEN trademark a serial number of 78063911. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 3, 2010. This trademark is owned by Lipoxen Technologies Limited. The POLYXEN trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical products used in industry and science, namely, proteins, peptides, small molecules, liposomes, niosomes and viruses for use in the manufacturing of DNA vaccines using formulations directed towards the immune system

Pharmaceutical preparations for the treatment of immunodeficiency diseases and illnesses and therapeutic preparations, namely, proteins, peptides, small molecules, liposomes, niosomes and viruses for enhancing the effectiveness and convenience of DNA vaccines using formulations directed towards the immune system; pharmaceutical preparations, namely, liposomal drugs for the treatment of immunodeficiency diseases and illnesses; vaccines, DNA vaccines

Medical and scientific research; discovery, development and design of pharmaceutical and therapeutic preparations; product research and development; and providing information relating to drug delivery systems, vaccines, genetic vaccines and preparations for prolonging the active life of therapeutic preparations; licensing intellectual property and patents to others

General Information


Serial Number78063911
Word MarkPOLYXEN
Filing DateWednesday, May 16, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 3, 2010
Registration Number2836305
Registration DateTuesday, April 27, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 3, 2004

Trademark Statements


Goods and ServicesChemical products used in industry and science, namely, proteins, peptides, small molecules, liposomes, niosomes and viruses for use in the manufacturing of DNA vaccines using formulations directed towards the immune system
Goods and ServicesPharmaceutical preparations for the treatment of immunodeficiency diseases and illnesses and therapeutic preparations, namely, proteins, peptides, small molecules, liposomes, niosomes and viruses for enhancing the effectiveness and convenience of DNA vaccines using formulations directed towards the immune system; pharmaceutical preparations, namely, liposomal drugs for the treatment of immunodeficiency diseases and illnesses; vaccines, DNA vaccines
Goods and ServicesMedical and scientific research; discovery, development and design of pharmaceutical and therapeutic preparations; product research and development; and providing information relating to drug delivery systems, vaccines, genetic vaccines and preparations for prolonging the active life of therapeutic preparations; licensing intellectual property and patents to others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 3, 2010
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 3, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 3, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLipoxen Technologies Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLondon NW1 0NH
GB

Party NameLipoxen Technologies Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon W1N 3AA

Party NameLipoxen Technologies Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon W1N 3AA

Trademark Events


Event DateEvent Description
Friday, December 3, 2010CANCELLED SEC. 8 (6-YR)
Friday, September 8, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 8, 2006TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 27, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, February 3, 2004PUBLISHED FOR OPPOSITION
Wednesday, January 14, 2004NOTICE OF PUBLICATION
Monday, December 1, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 21, 2003ASSIGNED TO EXAMINER
Thursday, October 9, 2003Sec. 1(B) CLAIM DELETED
Thursday, October 9, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 5, 2003CASE FILE IN TICRS
Thursday, October 9, 2003PAPER RECEIVED
Thursday, April 10, 2003INQUIRY AS TO SUSPENSION MAILED
Tuesday, January 8, 2002LETTER OF SUSPENSION MAILED
Thursday, December 27, 2001ASSIGNED TO EXAMINER
Wednesday, October 31, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 13, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 10, 2001NON-FINAL ACTION MAILED
Wednesday, August 8, 2001ASSIGNED TO EXAMINER